Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Haemonetics News

    85,38 $ +5,28% +4,28 $
    In : 79,796 € | 18:35:03 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 881782
    ISIN: US4050241003
    US-Symbol: HAE
    Typ: Aktie

    Haemonetics News

    10.04.24 - PR Newswire
    Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
    Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 PR Newswire
    04.04.24 - PR Newswire
    Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
    Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge PR Newswire
    01.04.24 - PR Newswire
    Haemonetics Corporation Completes Acquisition of Attune Medical
    Haemonetics Corporation Completes Acquisition of Attune Medical PR Newswire
    05.03.24 - PR Newswire
    Haemonetics Announces Definitive Agreement to Acquire Attune Medical
    Haemonetics Announces Definitive Agreement to Acquire Attune Medical PR Newswire
    21.02.24 - PR Newswire
    Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
    Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference PR Newswire
    21.02.24 - PR Newswire
    Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
    Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day PR Newswire
    08.02.24 - PR Newswire
    Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
    Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire
    11.01.24 - PR Newswire
    Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
    Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 PR Newswire
    12.12.23 - PR Newswire
    Haemonetics Corporation Completes Acquisition of OpSens Inc.
    Haemonetics Corporation Completes Acquisition of OpSens Inc. PR Newswire
    07.12.23 - PR Newswire
    Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
    Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire
    02.11.23 - PR Newswire
    Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
    Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire
    10.10.23 - PR Newswire
    Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.
    Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. PR Newswire
    05.10.23 - PR Newswire
    Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023
    Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023 PR Newswire
    29.08.23 - PR Newswire
    Haemonetics Announces European Expansion for VASCADE® Vascular Closure System
    Haemonetics Announces European Expansion for VASCADE® Vascular Closure System PR Newswire
    08.08.23 - PR Newswire
    Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
    Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire
    07.08.23 - PR Newswire
    Diane M. Bryant Joins Haemonetics' Board of Directors
    Diane M. Bryant Joins Haemonetics' Board of Directors PR Newswire
    10.07.23 - PR Newswire
    /C O R R E C T I O N -- Haemonetics Corporation/
    /C O R R E C T I O N -- Haemonetics Corporation/ PR Newswire
    22.06.23 - PR Newswire
    Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System
    Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System PR Newswire
    11.05.23 - PR Newswire
    Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
    Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website PR Newswire
    25.04.23 - PR Newswire
    Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023
    Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023 PR Newswire

    Newssuche

    Videos

    09:10 Uhr -3,48%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »